BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11752364)

  • 21. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
    Steinhilber D
    Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
    [No Abstract]   [Full Text] [Related]  

  • 22. Acetaminophen, aspirin, and renal failure.
    Thurlow W
    N Engl J Med; 2002 May; 346(20):1588-9; author reply 1588-9. PubMed ID: 12017163
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract]   [Full Text] [Related]  

  • 24. Aspirin and other anti-inflammatory drugs.
    Vane SJ
    Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S3-9. PubMed ID: 10992545
    [No Abstract]   [Full Text] [Related]  

  • 25. COX-2 inhibition: not too hot, not too cold--(perhaps) just right?
    Bakowsky V; Hanly JG
    J Rheumatol; 2000 Dec; 27(12):2734-7. PubMed ID: 11128655
    [No Abstract]   [Full Text] [Related]  

  • 26. [Coxib: a feasible therapeutic alternative in patients with intolerance or hypersensitivity to acetilsallicilic acid, non-steroidal antiinflammatory drugs and paracetamol].
    Ramos-Bello D; Ramos-Niembro F
    Gac Med Mex; 2009; 145(6):505-15. PubMed ID: 20077869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development of COX2 inhibitors.
    Flower RJ
    Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitro.
    Munsterhjelm E; Niemi TT; Ylikorkala O; Silvanto M; Rosenberg PH
    Acta Anaesthesiol Scand; 2005 Jul; 49(6):840-6. PubMed ID: 15954969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
    Baigent C; Patrono C
    Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation.
    Galliard-Grigioni KS; Fehr M; Reinhart WH
    Eur J Pharmacol; 2008 Oct; 595(1-3):65-8. PubMed ID: 18700139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonsteroidal anti-inflammatory drugs and paracetamol in children.
    Camu F; Van de Velde A; Vanlersberghe C
    Acta Anaesthesiol Belg; 2001; 52(1):13-20. PubMed ID: 11307652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy with preferential and specific COX-2 inhibitors].
    Stichtenoth DO; Frölich JC
    Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
    Weir MR; Sperling RS; Reicin A; Gertz BJ
    Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B; Brune K
    Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
    [No Abstract]   [Full Text] [Related]  

  • 36. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [COX-2 specific inhibitors are similar--and different].
    Aly A
    Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393
    [No Abstract]   [Full Text] [Related]  

  • 38. [Colorectal cancer and inhibition of cyclooxygenase-2].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
    [No Abstract]   [Full Text] [Related]  

  • 39. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
    Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
    [No Abstract]   [Full Text] [Related]  

  • 40. [A heterogenous drug class. NSAID: classification and spectrum of action].
    Ulbrich H; Dannhardt G
    Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.